UBM — Ulisse Biomed Spa Balance Sheet
0.000.00%
- €22.13m
- €19.83m
- €0.07m
Annual balance sheet for Ulisse Biomed Spa, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.776 | 0.043 | 4.99 | 3.79 | 2.31 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.511 | 0.774 | 1.16 | 1.04 | 0.961 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 1.37 | 0.89 | 6.24 | 4.96 | 3.58 |
Net Property, Plant And Equipment | 0.152 | 0.111 | 0.071 | 0.112 | 0.111 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 1.55 | 1.87 | 8.02 | 6.57 | 31.2 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.775 | 0.297 | 0.36 | 0.313 | 1.15 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.88 | 0.308 | 0.766 | 0.627 | 1.5 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 0.668 | 1.56 | 7.25 | 5.95 | 29.7 |
Total Liabilities & Shareholders' Equity | 1.55 | 1.87 | 8.02 | 6.57 | 31.2 |
Total Common Shares Outstanding |